Current share price for IPX : $3.600 0.16 (4.65%)+
IperionX Limited (IPX, formerly Hyperion Metals Limited) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is an American producer of titanium alloys, titanium products, and critical minerals, using patented metal technologies to produce performance titanium alloys, from titanium minerals or scrap titanium, at lower energy, cost and carbon emissions. Founded in 2020, It is a public company listed on both the Nasdaq and the ASX.
| ASX Code | IPX |
| Website | http://www.iperionx.com |
| Industry/Sector | Precious Metals & Minerals |
| Market Cap ($M) | 1,304 |
| IPX Share Price | $3.600 |
| Day High | $3.610 |
| Day Low | $3.400 |
| Last Close | $3.440 |
| IPX Share Price Movement | $0.16 ( 4.65% ) |
As a significant Australian company by market capitalisation, IPX is held across 21 ETFs spanning strategies that include precious metals & minerals exposure . Its weighting in those funds means performance can have an outsized influence - when IPX moves, funds like ISO, SSO, VSO, QRE and OZR that hold it can move with it.
For more concentrated exposure, ETFs such as ISO (iShares S&P/ASX Small Ordinaries ETF Index Fund) allocate about 0.4% to IPX , while the average exposure across all 21 ETFs that hold it is around 0.1% .
Last updated: ETF data and holdings as at 10 August 2026
How does holding IperionX Limited (IPX) shares directly compare to ETFs that include it?
|
IPX Direct
|
ISO
ASX |
SSO
ASX |
VSO
ASX |
QRE
ASX |
OZR
ASX |
|
|---|---|---|---|---|---|---|
| Holdings | 1 company | 198 holdings | 201 holdings | 193 holdings | 56 holdings | 92 holdings |
| IPX Weight | 100% | 0.4% | 0.4% | 0.2% | 0.1% | 0.1% |
| Diversification | Single Stock | Broad | Broad | Broad | Broad | Broad |
| Annual Cost | Brokerage only | 0.55% p.a. | 0.5% p.a. | 0.3% p.a. | 0.34% p.a. | 0.34% p.a. |
| Approx. Yield | - | 4.17% | 8.87% | 4.59% | 2.17% | 2.24% |
| Star Ratings | - |
Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not IPX's direct yield. Annual cost uses each ETF's MER.
How a $10,000 investment in IperionX Limited (IPX) one week ago compares with ETFs that hold it.
| Security | Investment type | Current price | 7-day price movement | Dollar change | Value today |
|---|---|---|---|---|---|
| IperionX Limited (IPX) | Direct share | $3.600 | 19.60% | +$1,960 | $11,960 |
| iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) | Equity - Australia Small/Mid Cap | $5.240 | 6.07% | +$607 | $10,607 |
| SPDR S&P/ASX Small Ordinaries Fund (SSO) | Equity - Australia Small/Mid Cap | $15.120 | 6.48% | +$648 | $10,648 |
| Vanguard MSCI Australian Small Companies Index ETF (VSO) | Equity - Australia Small/Mid Cap | $76.130 | 6.34% | +$634 | $10,634 |
| Betashares Australian Resources Sector ETF (QRE) | Equity - Australia Sectors | $10.410 | 7.32% | +$732 | $10,732 |
| SPDR S&P/ASX200 Resources Fund (OZR) | Equity - Australia Sectors | $18.170 | 7.64% | +$764 | $10,764 |
Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.
21 ETFs hold IperionX Limited (IPX).
| ETF | IPX Weight | MER | Yield |
|---|---|---|---|
| iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) | 0.4% | 0.55% | 4.17% |
| SPDR S&P/ASX Small Ordinaries Fund (SSO) | 0.4% | 0.5% | 8.87% |
| Vanguard MSCI Australian Small Companies Index ETF (VSO) | 0.2% | 0.3% | 4.59% |
| Betashares Australian Resources Sector ETF (QRE) | 0.1% | 0.34% | 2.17% |
| SPDR S&P/ASX200 Resources Fund (OZR) | 0.1% | 0.34% | 2.24% |
| Betashares Australian Ex-20 Portfolio Diversifier ETF (EX20) | 0.1% | 0.25% | 2.71% |
| Betashares Geared Australian Equity Fund (GEAR) | 0.1% | 2.11% | 1.67% |
| Vanguard Ethically Conscious Australian Shares ETF (VETH) | 0.1% | 0.16% | 2.74% |
| iShares Core MSCI Australia ESG Leaders ETF (IESG) | 0.1% | 0.09% | 2.45% |
| Plato Global Alpha Fund Complex ETF (PGA1) | 0.1% | 0.85% | - |
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Final | 3¢ | 100% | 18 Nov 2008 | 16 Dec 2008 | - | - | - |
See all dividends from IperionX Limited (IPX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2027F | C2 | -$6.10 | -61.90% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2026F | C2 | -$16.00 | -12.30% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2025A | -$53.97 | -$18.20 | 21.30% | 0.00 | 0.00 | 0.00% | 0.0% |
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 A | 2026 F | 2027 F | 2025 A | 2026 F | 2027 F | 2025 A | 2026 F | 2027 F | ||
| IperionX Limited (IPX) | $1,246M | 0.2128 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 3.00 | 0.00 | 8.16 | 0.00 |
| Market | 0.31 | 13.10 | 1.15 | 0.69 |
| Sector | 2.16 | 15.50 | 1.70 | 0.32 |
| Name | Position | Start Date |
|---|---|---|
| Mr Anastasios (Taso) Arima | Chief Executive Officer, Founder, Executive Director, Managing Director | 1 Dec 2020 |
| Mr Todd William Hannigan | Executive Chairman, Executive Director | 1 Feb 2021 |
| Mr Vaughn Taylor | Non-Executive Director | 3 Mar 2021 |
| Ms Melissa G Waller | Non-Executive Director | 13 Sep 2021 |
| Ms Beverly M Wyse | Non-Executive Director | 13 Sep 2021 |
| Mr R Tony Tripeny | Non-Executive Director | 17 Mar 2025 |
| Mr Michael J Loparco | Non-Executive Director | 3 Aug 2026 |
| Ms Lorraine M Martin | Non-Executive Director, Lead Independent Director. | 13 Sep 2021 |
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 15 Jul 2026 | WYSE, Beverly | Buy | Direct Shares | 106,093 | $0.870 | $92,300.910 |
| 15 Jul 2026 | WYSE, Beverly | Exercise | Options | 106,093 | $0.870 | $92,300.910 |
| 14 Jul 2026 | TRIPENY, R | Buy | Direct Shares | 38,460 | $2.600 | $99,996.000 |
See all changes in directors' interest & trades for IperionX Limited (IPX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
| Name | Position |
|---|---|
| Dominic P Allen | Chief Commercial Officer |
| Marcela Castro | Chief Financial Officer |
| W Scott Sparks | Chief Operating Officer |
| Louisa Anne Martino (Youens) | Company Secretary |
| Toby E Symonds | President and Chief Strategy Officer |
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in IperionX Limited (IPX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 45,802,651 (13.72%) | The Bank of New York Mellon Corporation |
| 26,097,578 (7.81%) | FMR LLC and and the entities |
| 25,443,775 (7.61%) | DITM Holdings Pty Ltd |
| Date | Event |
|---|---|
| 29 July 2027 | Report (Quarterly) |
| 26 April 2027 | Report (Quarterly) |
| 29 January 2027 | Report (Quarterly) |
| 29 October 2026 | Report (Quarterly) |
| 29 September 2026 | Report (Annual) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.